ACST Share Price Performance

ACST Community Fair Values

View all narratives

Recent ACST News & Updates

No updates

Acasti Pharma Inc. Key Details

Last Reported Earnings

Dec 31, 2022

Next Reporting Earnings

n/a

Earnings per share (EPS): -0.39
Gross Margin: 0%
Net Profit Margin: 0%
Debt/Equity Ratio: 0%

View full report ›

Acasti Pharma Inc. Competitors

About ACST

Founded: 2002
Employees: n/a
CEO: Prashant Kohli
WebsiteView website: www.acastipharma.com

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Canadian Market Performance

0.8%

12.7%

17.9%

10.2%

In the last week, the market has been flat, with a notable exception in the Healthcare sector dropping 3.7%. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›

Acasti Pharma Stock Price

ACST Share Price Performance

ACST Community Fair Values

Recent ACST News & Updates

Acasti Pharma Inc. Key Details

Acasti Pharma Inc. Competitors

Voice Mobility International

KP3993 Resources

Paloma Resources

China Keli Electric

Ronin Ventures

GCC Global Capital

SQID Technologies

Kua Investments

🇪🇺 🇬🇧 Momentum Is Returning to European and UK Markets

The Big Beautiful Deficit